Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bigot

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 10, 2009
[Evidence-based medicine and French medical students: an appraisal]M Orsat, P Bigot, M Rouprêt, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 10, 2019
Who is dying after nephrectomy for cancer? Study of risk factors and causes of death after analyzing morbidity and mortality reviews (UroCCR-33 study)A Fontenil, P Bigot, J-C Bernhard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 11, 2021
[Renal cell carcinoma of the kidney transplant: The French guidelines from CTAFU]X Tillou, A Doerfler, N Szabla, et al.
International Urology and Nephrology|September 4, 2020
Immediate preoperative renal artery embolization in the resection of complex renal tumors (UroCCR-48 Reinbol study)C Alegorides, P Bigot, J Hardwigsen, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 11, 2021
[Renal cell carcinoma in candidates for renal transplantation and recipients of a kidney transplant: The French guidelines from CTAFU]A Goujon, G Verhoest, F Sallusto, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2010
[Prognostic value of erythrocyte polyamines levels in renal cell carcinoma. Prospective study in 418 cases]P Bigot, G Lughezzani, K Bensalah, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 18, 2010
[Teaching and perception of urology by medical students at the end of the second cycle: an appraisal]P Bigot, B Campillo, M Orsat, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON StudyP Barthelemy, A Thiery-Vuillemin, T Lebret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 17, 2016
[CCAFU french national guidelines 2016-2018 on renal cancer]K Bensalah, L Albiges, J-C Bernhard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]E Compérat, S Larré, Y Neuzillet, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 10, 2009
[Evidence-based medicine and French medical students: an appraisal]M Orsat, P Bigot, M Rouprêt, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 10, 2019
Who is dying after nephrectomy for cancer? Study of risk factors and causes of death after analyzing morbidity and mortality reviews (UroCCR-33 study)A Fontenil, P Bigot, J-C Bernhard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 11, 2021
[Renal cell carcinoma of the kidney transplant: The French guidelines from CTAFU]X Tillou, A Doerfler, N Szabla, et al.
International Urology and Nephrology|September 4, 2020
Immediate preoperative renal artery embolization in the resection of complex renal tumors (UroCCR-48 Reinbol study)C Alegorides, P Bigot, J Hardwigsen, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 11, 2021
[Renal cell carcinoma in candidates for renal transplantation and recipients of a kidney transplant: The French guidelines from CTAFU]A Goujon, G Verhoest, F Sallusto, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2010
[Prognostic value of erythrocyte polyamines levels in renal cell carcinoma. Prospective study in 418 cases]P Bigot, G Lughezzani, K Bensalah, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 18, 2010
[Teaching and perception of urology by medical students at the end of the second cycle: an appraisal]P Bigot, B Campillo, M Orsat, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON StudyP Barthelemy, A Thiery-Vuillemin, T Lebret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 17, 2016
[CCAFU french national guidelines 2016-2018 on renal cancer]K Bensalah, L Albiges, J-C Bernhard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]E Compérat, S Larré, Y Neuzillet, et al.
Pageof 10